The top 100 stock
market authors
selected for publication
market authors
selected for publication
Barr Pharmaceuticals Inc. (BRL) ()
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Barr Pharmaceuticals Inc. (BRL) by latest | most commented
- A Look at D.E. Shaw's Q408 Holdings: Just for Fun
- Farallon Capital's Q408: Betting on MasterCard
- Eric Mindich's Eton Park Capital Likes Gold
- Moore Capital Investments: Theme Is Economic Recovery
- Caxton Associates 13F Filing for Q408
- Hedge Fund Portfolio Tracking: Paulson & Co., Q4 2008
- A Comparison of M&A Activity During Bull and Bear markets
- Hedge Fund Portfolio Tracking: SAC Capital (Steven Cohen), Q3 2008
- Hedge Fund Tracking: Farallon Capital Management (Thomas Steyer), Q3 2008
- Generic Drug Price War Ramps Up
- Five Things Worth Remembering About Healthcare in 2009
- Hedge Fund Tracking: Eton Park Capital (Eric Mindich), Q3 2008
- FDA Calendar Update: High Hopes for Amgen's Bone Drug
- Hedge Fund Tracking: Moore Capital Management (Louis Bacon), Q3 2008
- Strong Dollar's Impact on Pharma vs. Generics
- Hedge Fund Tracking: Paulson & Co. (John Paulson), Q3 2008
- 11 Updated Stocks and the Sad Story They Tell
- New Healthcare Cost Containment Index
- What Are Some of the Best Hedge Fund Managers Doing?
- Teva Beats On Profits
- Bullish Outlook for Generic Drugs Post-Election
- Only Abatement of Risk Aversion Will Stop VIX from Further Fall - JP Morgan Strategist
- Best and Worst Performing S&P 500 Stocks, YTD
- Generic Drug Industry Outperforms Drug and Healthcare ETFs
- Biggest Gainers, Losers Since 9/29
- Overview and Analysis of the Global Generic Drug Industry
- Summer Surge for Pharma Powers IHE, but Concerns Remain
- Merger Watch: Barr Pharmaceuticals - Teva Pharmaceutical
- Sector and Stock Performance Since Oil's Peak
- Big Pharma’s Healthy Appetite for Acquisitions
- Board and Executive Compensation in S&P 500
- Watch for More Coming Biotech Acquisitions
- S&P 500's Best and Worst Net Income Change
- Gannon On Investing's July 2008 Blogger Roundtable
- Teva Buys Barr Pharmaceuticals
- Friday Options Update: MSFT, BAC, MIR, OSTK, GILD, BRL, MAT
- Wall Street Breakfast: Must-Know News
- Is Teva Looking to Buy Barr Pharmaceuticals?
- Wednesday Options Outlook: XLF, MSFT, BRL, CCL, ARM, BWA, PXP, VIX
- Barr and Mylan Invalidate Boehringer Ingelheim's Patent on Mirapex
- Wall Street Breakfast: Must-Know News
-
The Seeking Alpha 100
See all
Seeking Alpha 100 » -
Fastest Climbers
Authors with the largest
increase in followers
in the last 7 days-
1
David Fry
-
2
Philip Davis
-
3
Bill Gross
-
4
Tyler Durden
-
5
TraderMark
Fastest Climbers » -
1
-
Top Commenters
Top commenters,See all
as ranked by their peers
Top Commenters » -
Top Instabloggers
The 100 most activeSee all
Instabloggers.
Top Instabloggers » -
Top StockTalkers
TopSee all
StockTalkers.
Top StockTalkers »
